Principal Investigator

Gerry Lipshutz, MD, MS


Professor in Residence
Departments of Surgery and Molecular and Medical Pharmacology
Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC)
Intellectual and Developmental Disabilities Research Center at UCLA
Semel Institute for Neuroscience
University of California at Los Angeles (UCLA)

Gerald S. Lipshutz, MD, MS, received his medical degree from the University of California Los Angeles (UCLA) School of Medicine and completed his postgraduate training at the University of California San Francisco School of Medicine.  Dr. Lipshutz has earned a Professor-in-Residence position within the Departments of Surgery and the Department of Molecular and Medical Pharmacology. He is also a member of the Intellectual and Developmental Disabilities Institute at UCLA along with the Broad Center; he presently holds the Goldwyn Chair Clinically. Within the David Geffen School of Medicine he is the Chairman of the Academic Medicine College. His clinical specialty and interests include liver and pancreas transplantation and gene and cell therapies for single gene metabolic disorders of the liver. Dr. Lipshutz has been an invited participant in many National Institutes of Health (NIH) conferences and has served as a grant reviewer for both Wellcome Trust, UK and the US National Institutes of Health where he is presently a standing member of the GDD Study Section

In addition to authoring over 70 peer-reviewed research papers, Dr. Lipshutz also serves on the editorial board for the Molecular Therapy, Methods and Clinical Development, and Gene Therapy. He is a member of several surgical, transplant, and gene and cell therapy societies including ASGCT and SIMD. As a principal investigator at the UCLA Lipshutz Hepatic Regenerative Medical Lab, Dr. Lipshutz’s research focuses on regenerative medicine technologies for the investigation and treatment of urea cycle disorders; he aims to develop new therapies that would replace liver transplantation for single-enzyme metabolic deficiencies and to understand the neurological effect of arginase deficiency with hyperargininemia. He is also a PI for multiple NIH grants and industry-sponsored studies for gene therapies.


635 Charles E. Young Drive South
NRB 379
Los Angeles, CA 90095
Tel: 310-267-9592